Rustom Antia
Overview
Explore the profile of Rustom Antia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
4998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faliti C, Van T, Anam F, Cheedarla N, Williams M, Mishra A, et al.
Nat Immunol
. 2024 Dec;
26(1):148.
PMID: 39622950
No abstract available.
2.
Chen Z, Ahmed H, Hirst C, Antia R
Bull Math Biol
. 2024 Nov;
87(1):8.
PMID: 39609321
In vivo in infection, virions are constantly produced and die rapidly. In contrast, most antibody binding assays do not include such features. Motivated by this, we considered virions with n ...
3.
Faliti C, Van T, Anam F, Cheedarla N, Williams M, Mishra A, et al.
Nat Immunol
. 2024 Nov;
26(1):131-145.
PMID: 39533072
Severe acute respiratory syndrome coronavirus 2 mRNA vaccination has reduced effectiveness in certain immunocompromised individuals. However, the cellular mechanisms underlying these defects, as well as the contribution of disease-induced cellular...
4.
Bull J, Koelle K, Antia R
bioRxiv
. 2024 Aug;
PMID: 39091870
Reinfections with respiratory viruses such as influenza viruses and coronaviruses are thought to be driven by ongoing antigenic immune escape in the viral population. However, this does not explain why...
5.
Chen Z, Ahmed H, Hirst C, Antia R
ArXiv
. 2024 May;
PMID: 38800656
In vivo in infection, virions are constantly produced and die rapidly. In contrast, most antibody binding assays do not include such features. Motivated by this, we considered virions with n=100...
6.
Streicker D, Griffiths M, Antia R, Bergner L, Bowman P, de Moraes M, et al.
Science
. 2024 Apr;
384(6693):275-277.
PMID: 38669579
Intrinsically safe designs and a staged transparent development process will be essential.
7.
Bull J, Nuismer S, Remien C, Griffiths M, Antia R
Expert Rev Vaccines
. 2024 Feb;
23(1):294-302.
PMID: 38372241
Introduction: Transmissible vaccines offer a novel approach to suppressing viruses in wildlife populations, with possible applications against viruses that infect humans as zoonoses - Lassa, Ebola, rabies. To ensure safety,...
8.
Aggarwal C, Ahmed H, Sharma P, Reddy E, Nayak K, Singla M, et al.
Nat Med
. 2024 Feb;
30(3):670-674.
PMID: 38321219
Dengue is a global epidemic causing over 100 million cases annually. The clinical symptoms range from mild fever to severe hemorrhage and shock, including some fatalities. The current paradigm is...
9.
Uddback I, Michalets S, Saha A, Mattingly C, Kost K, Williams M, et al.
Nature
. 2023 Dec;
626(7998):392-400.
PMID: 38086420
An ideal vaccine both attenuates virus growth and disease in infected individuals and reduces the spread of infections in the population, thereby generating herd immunity. Although this strategy has proved...
10.
Mariniello A, Nasti T, Chang D, Hashimoto M, Malik S, McManus D, et al.
Clin Cancer Res
. 2023 Nov;
30(9):1833-1845.
PMID: 37992307
Purpose: Combination of chemotherapy with programmed cell death 1 (PD-1) blockade is a front-line treatment for lung cancer. However, it remains unknown whether and how chemotherapy affects the response of...